ESTRO 2021 Abstract Book

Joint symposium ESTRO-RANZCR - Challenges and benefits of SBRT........................................................................................(abs. 241 - 244) ESTRO-ESR: MRI-guided radiotherapy in gynaecological cancer treatment................................................(abs. 245 - 248) ESTRO-EFOMP: New radiotherapy technology - What does it mean for radioprotection..........................(abs. 249 - 252)

Symposium Novel planning approaches for uncertanties in GTV delineation a

nd microscopic disease around GTVs. ............................................................................................................(abs. 253 - 255) Opportunities for RTTs in higher education: Making the right choice.........................................................(abs. 256 - 258) Salvage brachytherapy for breast cancer.......................................................................................................(abs. 259 - 262) Poster highlights Poster highlights 9: Intra-fraction motion management...............................................................................(abs. 263 - 269) Poster Highlights 10: Lung................................................................................................................................(abs. 270 - 276) Proffered papers Proffered papers 14: Hypoxia and tumour microenvironment...................................................................(abs. 277 - 282) Proffered papers 15: Radiobiology of normal tissues...................................................................................(abs. 283 - 288) Proffered papers 16: Late-breaking abstracts................................................................................................(abs. 289 - 294) Proffered papers 17: Gynaecological..............................................................................................................(abs. 295 - 300) Proffered papers 18: Training and implementation for new technologies.................................................(abs. 301 - 306) Proffered papers 19: Plan optimisation and algorithms...............................................................................(abs. 307 - 312) Proffered papers 20: Education and training.................................................................................................(abs. 313 - 318) Poster highlights Poster highlights 11: Dosimetry 1....................................................................................................................(abs. 319 - 325) Poster highlights 12: Miscellaneous................................................................................................................(abs. 326 - 332) Proffered papers Highlights of Proffered Papers - Latest Clinical Trials....................................................................................(abs. 333 - 338) Joint symposium ESTRO-JASTRO - Current status of hyperthermia in radiation oncology......................................................(abs. 339 - 344) Symposium Novel model systems for radiobiology research............................................................................................(abs. 345 - 348) Multiple and multifocal SBRT in advanced disease........................................................................................(abs. 349 - 352) Update in advanced breast cancer..................................................................................................................(abs. 353 - 356) Proffered papers Proffered papers 21: Motion management....................................................................................................(abs. 357 - 364) Symposium Automatic contouring: Metrics and clinical evaluation approaches............................................................(abs. 365 - 368) Working with infections/contagious pateitns - COVID-19.............................................................................(abs. 369 - 371) Next generation of brachytherapy treatment planning systems: What do we want and what do they need?.....................................................................................................(abs. 372 - 374) Poster highlights Poster highlights 13: Treatment planning 2....................................................................................................(abs. 375 - 381) Poster highlights 14: Head and neck 2............................................................................................................(abs. 382 - 388) Award lecture C Regaud Award................................................................................................................................................(abs. 389 - 390) Iridium Award....................................................................................................................................................(abs. 391 - 392) Proffered papers Proffered papers 22: Functional and biological imaging...............................................................................(abs. 393 - 398) Proffered papers 23: Radiation response and biomarkers...........................................................................(abs. 399 - 404) Proffered papers 24: Palliation........................................................................................................................(abs. 405 - 410) Proffered papers 25: Upper GI.........................................................................................................................(abs. 411 - 416) Proffered papers 26: Treatment planning for proton therapy.....................................................................(abs. 417 - 422) Proffered papers 27: Large-scale assurance of quality.................................................................................(abs. 423 - 428) Poster highlights Poster highlights 15: Image-guided innovations in radiotherapy. ...............................................................(abs. 429 - 434) Poster highlights 16: Radiobiology..................................................................................................................(abs. 435 - 441) Poster highlights 17: Gynaecological...............................................................................................................(abs. 442 - 448)